Mirla Avila, MD, explores updates to the 2024 McDonald criteria and the role of emerging diagnostic tools, as well as conditions clinicians should consider when evaluating potential MS mimics.
Transcript
A lot has changed in the new criteria. CT and visual evoked potentials are now among the tools that can help us diagnose MS. A spinal tap isn’t always necessary, but it can provide more information and help rule out conditions that mimic MS.
When an MRI shows lesions highly suspicious for MS—especially in the periventricular area, where they’re called Dawson’s fingers—and the patient has also had clinical symptoms of MS, that can guide us toward a diagnosis. We also use blood tests to rule out other conditions, such as Lyme disease, sarcoidosis, and rheumatologic disorders.
With the 2024 criteria, another change is that we can look for the central vein sign on MRI. This wasn’t part of the previous criteria. Detecting it can be more challenging because it requires specific imaging sequences, which aren’t always included when an MRI is ordered. It’s better to use a 3-tesla MRI; the sign may not be visible on a 1.5-tesla scan. So, the MRI technique is also something to consider.